First-line cisplatin + S-1 +/- nimotuzumab in patients with advanced gastric cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 05 Jun 2012 Interim results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 22 Jun 2011 New trial record
- 07 Jun 2011 Interim results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.